Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Mehdi Touat, M.D.

Concepts (276)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Mehdi Touat's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Mehdi Touat has written about over time.
Receptors, Fibroblast Growth Factor, 1 publications between 2015 and 2015, average publication date June 2015. Molecular Targeted Therapy, 6 publications between 2015 and 2023, average publication date August 2017. Myositis, 3 publications between 2016 and 2019, average publication date January 2018. Multiple Acyl Coenzyme A Dehydrogenase Deficiency, 1 publications between 2018 and 2018, average publication date July 2018. Riboflavin, 1 publications between 2018 and 2018, average publication date July 2018. Oligodendroglioma, 3 publications between 2016 and 2020, average publication date September 2018. Isocitrate Dehydrogenase, 11 publications between 2015 and 2023, average publication date October 2019. Drug Resistance, Bacterial, 3 publications between 2019 and 2021, average publication date December 2019. Azetidines, 2 publications between 2018 and 2021, average publication date January 2020. Ganglioglioma, 2 publications between 2018 and 2021, average publication date January 2020. Hospital Costs, 2 publications between 2019 and 2021, average publication date April 2020. Brain Neoplasms, 32 publications between 2015 and 2024, average publication date May 2020. Glioblastoma, 13 publications between 2015 and 2024, average publication date July 2020. Azacitidine, 1 publications between 2020 and 2020, average publication date August 2020. Mutation, 16 publications between 2018 and 2024, average publication date September 2020. Aftercare, 1 publications between 2021 and 2021, average publication date February 2021. Glioma, 17 publications between 2015 and 2023, average publication date March 2021. Astrocytoma, 4 publications between 2016 and 2023, average publication date May 2021. Lymphoma, 2 publications between 2021 and 2022, average publication date December 2021.

To see the data from this visualization as text, click here.
Touat's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (276)
Explore
_
Co-Authors (56)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.